| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Rasoi Limited |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Non-Current Assets |
|
|
|
Property, Plant & Equipment |
1,46,227 |
1,51,170 |
|
Investment in Associate |
56,02,613 |
49,26,082 |
|
Other Investments |
2,95,328 |
2,73,024 |
|
Loans |
1,20,200 |
1,13,200 |
|
Other Financial Assets |
14,431 |
15,296 |
|
Other Non Current Assets |
50,836 |
51,072 |
|
Current Assets |
|
|
|
Inventories |
30,927 |
25,939 |
|
Investments |
5,51,246 |
2,52,495 |
|
Cash & Cash Equivalents |
9,265 |
8,631 |
|
Bank Balances (other than above) |
12 |
45 |
|
Loans |
11,855 |
7,840 |
|
Other Financial Assets |
39,239 |
3,72,498 |
|
Current Tax Assets
(Net) |
1,376 |
8,106 |
|
Other Current Assets |
615 |
901 |
|
Total Assets |
68,74,170 |
62,06,299 |
|
Equity |
|
|
|
Equity Share Capital |
19,320 |
19,320 |
|
Other Equity |
68,35,600 |
61,70,271 |
|
Non-Current Liabilities |
|
|
|
Provisions |
2,377 |
2,180 |
|
Deferred Tax Liabilities (Net) |
9,695 |
8,471 |
|
Current Liabilities |
|
|
|
Trade payables |
|
|
|
Outstanding dues of micro & small enterprises |
449 |
157 |
|
Outstanding dues of creditors other than above |
404 |
4,809 |
|
Other Financial Liabilities |
12 |
45 |
|
Other Current Liabilities |
5,469 |
203 |
|
Provisions |
844 |
843 |
|
Total Equity & Liabilities |
68,74,170 |
62,06,299 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Income |
|
|
|
Revenue from Operations |
1,67,752 |
1,85,472 |
|
Other Income |
10,596 |
1,88,582 |
|
Total Revenue |
1,78,348 |
3,74,054 |
|
Expenses |
|
|
|
Cost of Material Consumed |
57,731 |
63,033 |
|
Purchase of Stock-in-Trade |
9,895 |
- |
|
Changes in Inventories |
-4,406 |
-4,678 |
|
Employee Benefits Expense |
30,372 |
31,155 |
|
Finance Cost |
- |
368 |
|
Depreciation & Amortisation |
8,787 |
10,982 |
|
Other Expenses |
82,863 |
84,817 |
|
Total Expenses |
1,85,242 |
1,85,677 |
|
Profit/(Loss)
Before Tax |
-6,894 |
1,88,377 |
|
Current Tax |
6,602 |
62,214 |
|
Deferred Tax |
3,012 |
-27,542 |
|
Excess provision w/back (earlier years) |
-73 |
-331 |
|
Profit for the Year (before associates) |
-16,435 |
1,54,036 |
|
Share of Profit of Associates |
1,93,691 |
1,96,342 |
|
Profit
for the Year |
1,77,256 |
3,50,378 |
|
Other Comprehensive income |
|
|
|
Items
that will not be reclassified to profit or loss |
5,20,416 |
1,33,174 |
|
Income tax relating to items that will not be reclassified to profit or loss |
41,957 |
15,441 |
|
items
that will be reclassified to profit or loss |
19,284 |
-6,647 |
|
Income tax relating to items that will be reclassified to profit or loss |
-5,365 |
385 |
|
Total Comprehensive Income |
6,69,634 |
2,26,383 |
|
Earnings
per share |
|
|
|
Basic & Diluted |
1,834.95 |
3,627.10 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Cash Flow from Operating Activities |
|
|
|
Profit Before Tax |
-6,894 |
1,88,377 |
|
Non-cash adjustments to reconcile profit before tax to net cash flows |
|
|
|
Depreciation |
8,787 |
10,982 |
|
Net gain on fair valuation of investments |
-1,120 |
19,509 |
|
Fair Value Adjustment - Actuarial Gain |
-270 |
3 |
|
Loss/(Profit) on Sale of PPE |
-9,387 |
-1,88,212 |
|
Finance Cost |
- |
368 |
|
Operating
Profit before Working Capital Changes |
-8,884 |
31,027 |
|
Increase/(Decrease) in Investments |
-3,11,240 |
82,286 |
|
Increase/(Decrease) in Inventories |
-4,988 |
-6,576 |
|
Increase/(Decrease) in Trade & other
receivables |
33,614 |
-11,102 |
|
Increase/(Decrease) in Trade & other payables |
1,350 |
5,678 |
|
Cash
Generated from Operations |
-2,90,148 |
89,957 |
|
Direct Taxes Paid (net of refunds) |
-4,775 |
-64,812 |
|
Net
Cash Flow from Operating Activities |
-2,94,923 |
25,145 |
|
Cash Flow from Investing Activities |
|
|
|
Purchase of Property, Plant & Equipment |
-4,057 |
-23,343 |
|
Proceeds from Sale of PPE |
9,599 |
1,93,670 |
|
Fixed Deposits |
2,90,016 |
-1,92,000 |
|
Net
Cash Flow from Investing Activities |
2,95,558 |
-21,673 |
|
Cash Flow from Financing Activities |
|
|
|
Interest Paid |
- |
-368 |
|
Dividend Paid on Equity Shares |
-34 |
-40 |
|
Net
Cash Flow from Financing Activities |
-34 |
-408 |
|
Net Increase/(Decrease) in Cash |
601 |
3,064 |
|
Cash & Cash Equivalents at Beginning of Year |
8,676 |
5,612 |
|
Cash
& Cash Equivalents at End of Year |
9,277 |
8,676 |
Summary
of cash flow statement for the year 2025 and 2024:
Cash Flow from Operating Activities:
The company reported a negative operating cash flow of ₹2,94,923 (‘000) in 2025
compared to a positive ₹25,145 (‘000) in 2024. This sharp decline is mainly
driven by a loss before tax (₹-6,894) versus strong profits in the previous year.
Additionally, a significant outflow due to increased investments (₹-3,11,240)
heavily impacted operating cash. Although there was some improvement from
receivables (cash inflow), it was insufficient to offset the large outflows.
Overall, this indicates weak core business cash generation in 2025. Adjustments
such as depreciation (₹8,787) provided a non-cash add-back, but gains like
profit on sale of PPE (₹-9,387) and fair valuation gains reduced operating
cash. Compared to 2024, where adjustments were more balanced, 2025 reflects
fewer supportive non-cash inflows. These adjustments contributed to lowering
the operating profit before working capital changes to a negative figure.
Working Capital Changes:
The working capital movement shows mixed trends. Trade receivables decreased
(₹33,614 inflow), which is positive as it indicates better collections.
However, inventories increased (₹-4,988), implying funds tied up in stock.
Trade payables increased slightly (₹1,350), offering minor support. The most
notable factor is the large increase in investments, which significantly
drained cash. Overall, working capital changes had a net negative impact on
liquidity.
Cash Flow from Investing Activities:
Investing activities generated a strong positive cash flow of ₹2,95,558 in 2025
compared to a negative ₹21,673 in 2024. This was mainly due to proceeds from
fixed deposits (₹2,90,016) and sale of PPE (₹9,599). The company reduced its
investments and liquidated assets to generate cash. While this improved
short-term liquidity, it may indicate asset monetization rather than
operational strength.
Cash Flow from Financing Activities:
Financing cash flow remained minimal, with a small outflow of ₹34 in 2025 (₹408
in 2024). There was no interest payment in 2025, consistent with the company’s
low debt levels. Dividend payments were also negligible. This reflects a stable
but inactive financing structure with minimal dependence on external funding.
Net Change in Cash Position:
Despite negative operating cash flow, the company recorded a slight net
increase in cash of ₹601 in 2025 (compared to ₹3,064 in 2024), primarily due to
strong inflows from investing activities. This indicates that liquidity was
maintained through asset liquidation rather than core operations.
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Current ratio |
89.79 |
111.69 |
|
Debt equity ratio |
0.01 |
0.01 |
|
Debt service coverage
ratio |
- |
576.42 |
|
Return on equity ratio |
-0.24% |
9.18% |
|
Inventory turnover ratio |
4.37 |
5.41 |
|
Trade payables turnover ratio |
58.48 |
18.69 |
|
Net capital turnover
ratio |
0.28 |
0.30 |
|
Net profit ratio |
-2.29% |
84.11% |
|
Return on capital employed |
0.31% |
11.61% |
|
Return on investment |
-0.24% |
9.18% |
Summary of financial ratios for the year 2025 and 2024:
Current
Ratio:
The current ratio declined from 111.69 in 2024 to 89.79 in 2025, though it
still remains extremely high. This indicates that the company continues to have
a very strong liquidity position, with current assets far exceeding current
liabilities. However, such an unusually high ratio may also suggest inefficient
utilization of short-term assets or excess idle resources.
Debt-Equity
Ratio:
The debt-equity ratio remained constant at 0.01 in both years, reflecting a
very low reliance on external debt. This indicates a conservative capital
structure with minimal financial risk, but it may also imply that the company
is not leveraging debt to enhance returns.
Debt
Service Coverage Ratio:
The DSCR was extremely high at 576.42 in 2024, indicating excellent ability to
service debt obligations. However, it is not reported in 2025, likely due to
negligible or no debt obligations during the year, consistent with the low
debt-equity ratio.
Return on
Equity:
ROE declined sharply from a positive 9.18% in 2024 to -0.24% in 2025. This
indicates that shareholders experienced a loss in value during 2025, reflecting
poor profitability compared to the previous year.
Inventory
Turnover Ratio:
The inventory turnover ratio decreased from 5.41 to 4.37, suggesting slower
movement of inventory. This may indicate reduced sales efficiency or
overstocking, which could tie up working capital.
Trade
Payables Turnover Ratio:
This ratio increased significantly from 18.69 to 58.48, indicating that the
company is paying its suppliers much faster than before. While this improves
supplier relationships, it may also reduce the benefit of credit terms and
impact cash flow.
Net
Capital Turnover Ratio:
The net capital turnover ratio slightly declined from 0.30 to 0.28, suggesting
marginally lower efficiency in utilizing capital to generate revenue.
Net
Profit Ratio:
The net profit ratio dropped drastically from a very high 84.11% in 2024 to
-2.29% in 2025. This indicates a shift from strong profitability to losses,
which is a major concern and suggests significant operational or financial
challenges.
Return on
Capital Employed:
ROCE decreased sharply from 11.61% to 0.31%, indicating that the company’s
efficiency in generating profits from its capital base has significantly
weakened.
Return on
Investment:
ROI followed a similar trend to ROE, declining from 9.18% to -0.24%. This
reflects poor returns on invested funds in 2025 and aligns with the overall
decline in profitability.